RUFFOLO ROBERT R 4
4 · Aridis Pharmaceuticals, Inc. · Filed Oct 5, 2021
Insider Transaction Report
Form 4
RUFFOLO ROBERT R
Director
Transactions
- Award
Stock Options
2021-10-04+7,000→ 49,791 totalExercise: $3.60Exp: 2031-10-04→ Common Stock (7,000 underlying)
Footnotes (1)
- [F1]The stock options vest in equal installments over 12 months, beginning on October 4, 2021.